Historique
Bulletin de Périodique
Addiction , Vol.110, Suppl.1 - February 2015 - Drug use and harm reduction in China
Auteur(s) :
WU, Z. (Éditeur scientifique) ;
WANG, Y. (Éditeur scientifique) ;
DETELS, R. (Éditeur scientifique) ;
BULTERYS, M. (Éditeur scientifique)
Paru le :
01/02/2015
Année
2015
Page(s) :
1-78
Sous-type de document :
N° spécial de revue / Special issue of a journal
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus géographique
CHINE
Thésaurus mots-clés
REDUCTION DES RISQUES ET DES DOMMAGES
;
VIH
;
TRAITEMENT DE MAINTENANCE
Note de contenu :
CONTENTS:
- Towards ending HIV/AIDS among drug users in China [Editorial]. Wu Z., Wang Y., Detels R., Bulterys M., p. 1-3.
- Tracking the evolution of drug abuse in China, 2003-10: a retrospective, self-controlled study. Jia Z., Liu Z., Chu P., McGoogan J.M., Cong M., Shi J., et al., p. 4-10.
- Club drug use and associated high-risk sexual behaviour in six provinces in China. Bao Y.-P., Liu Z.-M., Li J.-H., Zhang R.-M., Hao W., Zhao M., et al., p. 11-19.
- HIV epidemic among drug users in China: 1995-2011. Wang L., Guo W., Li D., Ding Z., McGoogan J.M., Wang N., et al., p. 20-28.
- Who uses methadone services in China? Monitoring the world's largest methadone programme. Sullivan S.G., Wu Z., Rou K., Pang L., Luo W., Wang C., et al., p. 29-39.
- Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme. Zhao Y., Shi C.X., McGoogan J.M., Rou K., Zhang F., Wu Z., p. 40-50.
- Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Yin W., Pang L., Cao X., McGoogan J.M., Liu M., Zhang C., et al., p. 51-60.
- Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China. Luo W., Wu Z., Poundstone K., McGoogan J.M., Dong W., Pang L., et al., p. 61-67.
- Health promotion interventions and policies addressing excessive alcohol use: a systematic review of national and global evidence as a guide to health-care reform in China. Li Q., Babor T.F., Zeigler D., Xuan Z., Morisky D., Hovell M.F., et al., p. 68-78.
- Towards ending HIV/AIDS among drug users in China [Editorial]. Wu Z., Wang Y., Detels R., Bulterys M., p. 1-3.
- Tracking the evolution of drug abuse in China, 2003-10: a retrospective, self-controlled study. Jia Z., Liu Z., Chu P., McGoogan J.M., Cong M., Shi J., et al., p. 4-10.
- Club drug use and associated high-risk sexual behaviour in six provinces in China. Bao Y.-P., Liu Z.-M., Li J.-H., Zhang R.-M., Hao W., Zhao M., et al., p. 11-19.
- HIV epidemic among drug users in China: 1995-2011. Wang L., Guo W., Li D., Ding Z., McGoogan J.M., Wang N., et al., p. 20-28.
- Who uses methadone services in China? Monitoring the world's largest methadone programme. Sullivan S.G., Wu Z., Rou K., Pang L., Luo W., Wang C., et al., p. 29-39.
- Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme. Zhao Y., Shi C.X., McGoogan J.M., Rou K., Zhang F., Wu Z., p. 40-50.
- Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Yin W., Pang L., Cao X., McGoogan J.M., Liu M., Zhang C., et al., p. 51-60.
- Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China. Luo W., Wu Z., Poundstone K., McGoogan J.M., Dong W., Pang L., et al., p. 61-67.
- Health promotion interventions and policies addressing excessive alcohol use: a systematic review of national and global evidence as a guide to health-care reform in China. Li Q., Babor T.F., Zeigler D., Xuan Z., Morisky D., Hovell M.F., et al., p. 68-78.
Résumé :
The 90-90-90 targets (i.e. by 2020, 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy and 90% of all people receiving antiretroviral therapy will have viral suppression) set by the Joint United Nations Programme on HIV/AIDS (UNAIDS) has provided a clear and pragmatic road map towards ending the HIV/AIDS epidemic by 2030. Ending HIV/AIDS among key populations is the first, critically important step. In the past decade, China has made remarkable progress in scaling-up harm reduction programs. However, both the drug use and HIV epidemics among drug users have evolved during the past decade, calling for new approaches. This special issue assembles a collection of papers which describe the changing landscape of drug use and the HIV epidemic, underscoring the need to further expand access to antiretroviral therapy (ART) and quality long-term HIV care for drug users in China. [Extract from the editorial]
Cote :
Abonnement